A Trial Investigating the Effect of 4 Weeks Dosing of XEN-D0501 on Blood Glucose Reduction in Patients With Diabetes

NCT05353686 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Efficacy
Safety
Pharmacokinetics
Diabetes Mellitus, Type 2

Interventions

DRUG: Placebo
DRUG: XEN-D0501

Sponsor

Pila Pharma

Collaborators

[object Object]